Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide
Royal Philips (NYSE: PHG) announced the 5,000th installation of its Zenition mobile C-arm system on October 8, 2025 at Kolín Regional Hospital in the Czech Republic.
Since launch in 2019, Zenition is deployed in 170+ countries and Philips reports its mobile C-arms help treat more than 15 million patients annually. The platform highlights features such as Position Memory and BodySmart software, with user tests cited showing a 45% reduction in C-arm repositioning.
Royal Philips (NYSE: PHG) ha annunciato la 5.000ª installazione del suo sistema C-arm mobile Zenition il 8 ottobre 2025 presso l'ospedale regionale di Kolín, in Repubblica Ceca.
Dal suo lancio nel 2019, Zenition è impiegato in 170+ paesi e Philips riporta che i suoi C-arm mobili aiutano a trattare più di 15 milioni di pazienti all'anno. La piattaforma mette in evidenza funzionalità quali Position Memory e software BodySmart, con test utente citati che mostrano una riduzione del 45% nel riposizionamento del C-arm.
Royal Philips (NYSE: PHG) anunció la 5.000ª instalación de su sistema móvil Zenition C-arm el 8 de octubre de 2025 en el Hospital Regional de Kolín, en la República Checa.
Desde su lanzamiento en 2019, Zenition se despliega en 170+ países y Philips informa que sus C-arms móviles ayudan a tratar más de 15 millones de pacientes al año. La plataforma destaca funcionalidades como Position Memory y el software BodySmart, con pruebas de usuario citadas que muestran una reducción del 45% en el recolocamiento del C-arm.
Royal Philips (NYSE: PHG)가 Zenition 모바일 C-암 시스템의 5,000번째 설치를 2025년 10월 8일에 체코 공화국의 콜린 지역 병원에서 발표했습니다.
2019년 출시 이후 Zenition은 170개 이상 국가에 배치되었으며 Philips는 모바일 C-암이 연간 1,500만 명이 넘는 환자 치료에 도움을 준다고 보고합니다. 이 플랫폼은 Position Memory 및 소프트웨어 BodySmart와 같은 기능을 강조하며, 사용자 테스트에 따르면 C-암 재배치가 45% 감소하는 것으로 나타났습니다.
Royal Philips (NYSE: PHG) a annoncé la 5 000e installation de son système C-arm mobile Zenition le 8 octobre 2025 à l'hôpital régional de Kolín en République tchèque.
Depuis son lancement en 2019, Zenition est déployé dans plus de 170 pays et Philips indique que ses C-arms mobiles aident à traiter plus de 15 millions de patients par an. La plateforme met en avant des fonctionnalités telles que Position Memory et le logiciel BodySmart, des tests utilisateurs cités montrant une réduction de 45% du repositionnement du C-arm.
Royal Philips (NYSE: PHG) kündigte die 5.000. Installation ihres mobilen Zenition C-Arm-Systems am 8. Oktober 2025 im Kolín Regional Hospital in der Tschechischen Republik an.
Seit dem Start im 2019 ist Zenition in 170+ Ländern eingesetzt, und Philips berichtet, dass seine mobilen C-Arm-Systeme helfen, mehr als 15 Millionen Patienten jährlich zu behandeln. Die Plattform hebt Funktionen wie Position Memory und die Software BodySmart hervor, wobei Benutzertests eine 45% Reduktion der Neupositionierung des C-Arms zeigen.
Royal Philips (NYSE: PHG) أعلنت عن التركيب رقم 5,000 لنظام Zenition C-arm المحمول في 8 أكتوبر 2025 في مستشفى كولين الإقليمي بجمهورية التشيك.
منذ الإطلاق في 2019، يتم نشر Zenition في أكثر من 170 دولة وتفيد Philips أن أذرع C-arm المحمولة تساعد في علاج أكثر من 15 مليون مريض سنوياً. تسلط المنصة الضوء على ميزات مثل Position Memory وبرنامج BodySmart، وتشير اختبارات المستخدمين إلى وجود خفض قدره 45% في إعادة وضع C-arm.
Royal Philips (NYSE: PHG) 宣布在捷克共和国科林地区医院完成其 Zenition 移动式 C 型臂系统的 第5,000次安装,时间为 2025年10月8日。
自 2019 年推出以来,Zenition 已在 170+ 国家部署, Philips 报告称其移动式 C 型臂每年帮助治疗 超过1500万名患者。该平台强调如 Position Memory 与软件 BodySmart 的功能,用户测试显示 C 型臂重新定位的 下降了 45%。
- 5,000 Zenition installations worldwide as of Oct 8, 2025
- Zenition deployed in 170+ countries
- Philips mobile C-arms help treat 15 million+ patients per year
- Zenition features Position Memory and BodySmart that cut repositioning by 45%
- None.
Insights
5,000 installations and claimed efficiency gains signal meaningful commercial adoption and product-market fit for the Zenition family.
Philips reports the 5,000th installation of its Zenition mobile C-arm at Kolín Regional Hospital, noting deployment across more than
Dependencies and risks are explicit in the release: the efficiency claim—reduced repositioning by
Items to watch in the near term include formal clinical or real-world outcome studies validating the operational claims, model-level shipment or revenue disclosures that break out Zenition contribution, and upgrade/recurring-service uptake among the installed base; expect relevant updates over the next 6–18 months.
October 8, 2025
Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 5,000th installation of its Philips Zenition mobile surgery imaging system at Kolín Regional Hospital in the Czech Republic. Since its launch in 2019, Zenition has become a trusted solution in hospitals across more than 170 countries, enabling surgeons and interventional teams to perform image-guided procedures more efficiently, supporting improved treatment outcomes. Every year, Philips mobile C-arm systems help to treat more than 15 million patients [1] worldwide, underscoring Philips’ commitment to delivering accessible and innovative solutions that help physicians to provide better care to more people.
As hospitals and surgical centers face mounting staff shortages and budget constraints, the Philips Zenition mobile C-arm platform is designed to deliver high-quality imaging with ease of use and workflow efficiency. The platform leverages industry leading innovations pioneered on Philips’ highly successful Azurion platform, supporting confident clinical decision-making while safeguarding patients and staff. Zenition’s compact design, Position Memory feature [2] and BodySmart software, which captures fast and consistent images, reduce the need for C-arm repositioning by
“Designed as an intuitive, impressively fast motorized C-arm, the Zenition efficiently delivers state-of-the-art image quality, said Filip Neumann, MUDr, Head of the Endoscopy Department at Kolín Regional Hospital, where the 5,000th Zenition has been installed. “The tableside operator and touch screen module provide motion and image control directly at the table, giving operators greater flexibility and independence.”
A legacy of innovation in mobile surgery imaging
The 5,000th installation coincides with the 70th anniversary of Philips introducing its first mobile C-arm in 1955, marking seven decades of continuous innovation in surgical imaging. Building on this heritage, the Zenition family brings together Philips’ expertise in image-guided therapy, workflow innovation, and clinical partnership to improve outcomes across a wide range of surgical specialties.
“Reaching 5,000 Zenition installations worldwide is a testament to the trust clinicians place in our solutions to deliver high-quality care,” said Mark Stoffels, Global Business Leader Image-Guided Therapy Systems at Philips.
“This milestone reflects both our rich 70-year heritage in surgical imaging and our continued commitment to helping healthcare providers overcome today’s challenges of staff shortages, efficiency pressures, and rising costs – so that more patients everywhere can benefit from safe, effective surgical care,” added Rohit Sathe, Global Business Leader, Mobile Surgery at Philips.
From Europe, North America, Middle East & Turkey to Asia and emerging markets, hospitals worldwide are endorsing Zenition for its ease of use, reliability, and clinical versatility. With flexible configurations and upgradability, the platform helps healthcare providers stay ahead of evolving clinical needs while ensuring long-term value.
For more information about Philips range of Zenition mobile X-ray systems, visit our website.
[1] Philips lives improved methodology
[2] Available on Zenition 90 Motorized, Zenition 90, Zenition 70 and Zenition 30 only.
[3] Results obtained during user tests performed in November 2013 by Use-Lab GmbH, an independent company. The tests involved 30 USA-based clinicians (15 physicians teamed up with 15 nurses or X-ray technicians), who performed simulated procedures using Philips mobile X-ray systems in a simulated OR environment. None of them had worked with each other before.
For further information, please contact:
Joost Maltha
Philips Global External Relations
Tel.: +31 6 1055816
E-mail: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
